Chauhan D P, Miller M S, Owens I S, Anderson L M
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research Facility, Md.
Dev Pharmacol Ther. 1991;16(3):139-49.
The ontogeny and transplacental inducibility of UDP-glucuronosyl transferase (UDPGT) activities potentially relevant to detoxification of polycyclic aromatic hydrocarbons were studied in (C57BL/6 x DBA/2) F1 or (DBA/2 x C57BL/6) F1 fetal mouse liver, with p-nitrophenol (PNP) and 3-hydroxybenzo[a]pyrene (3-OH-BP) as substrates. Both UDPGT activities developed during the late fetal period and reached almost 60% of the adult activity at term; PNP, but not 3-OH-BP UDPGT decreased significantly on postnatal day 1 before rising to adult levels. A single exposure to beta-naphthoflavone (beta NF; 150 mg/kg) on day 17 of gestation induced the PNP-UDPGT activity significantly (1.5-fold) by day 19 in the B6D2 F1s but not D2B6 F1s. A single dose of 3-methylcholanthrene (MC; 100 mg/kg) or 2,3,7,8,-tetrachlorodibenzo-p-dioxin (10 micrograms/kg) did not induce, but three injections of MC also resulted in significant induction in the fetuses of C57BL/6 mothers. 3-OH-BP-UDPGT was not significantly induced by any of the chemicals in either genetic cross. In a parallel study, a gene for an inducible mouse UDPGT, designated UDPGTm-1, was shown by Northern blotting to be expressed in fetal liver by day 18 of gestation at low levels relative to adults, but was not induced transplacentally by MC, beta NF or phenobarbital (PB). These results show that (1) at least two functionally defined UDPGT activities toward phenolic substrates are present in the late fetal mouse liver; (2) one of these is transplacentally inducible by beta NF and MC, but only in fetuses of C57BL/6 mothers, (3) induction where achieved was relatively small in magnitude, and (4) a gene of a PB-inducible UDPGT was expressed at low levels in the fetuses but was not induced transplacentally.
以对硝基苯酚(PNP)和3 - 羟基苯并[a]芘(3 - OH - BP)为底物,研究了与多环芳烃解毒潜在相关的UDP - 葡糖醛酸基转移酶(UDPGT)活性在(C57BL/6×DBA/2)F1或(DBA/2×C57BL/6)F1胎鼠肝脏中的个体发生及经胎盘诱导性。两种UDPGT活性在胎儿后期发育,足月时达到成年活性的近60%;PNP - UDPGT活性在出生后第1天显著下降,然后上升至成年水平,而3 - OH - BP - UDPGT活性则无此变化。妊娠第17天单次暴露于β - 萘黄酮(βNF;150 mg/kg)可使B6D2 F1胎鼠在第19天时PNP - UDPGT活性显著诱导(1.5倍),而D2B6 F1胎鼠则无此现象。单次剂量的3 - 甲基胆蒽(MC;100 mg/kg)或2,3,7,8 - 四氯二苯并 - p - 二恶英(10 μg/kg)未诱导出该活性,但三次注射MC可使C57BL/6母鼠的胎儿产生显著诱导。在任何一种遗传杂交中,3 - OH - BP - UDPGT均未被任何一种化学物质显著诱导。在一项平行研究中,通过Northern印迹法显示,一种可诱导的小鼠UDPGT基因(命名为UDPGTm - 1)在妊娠第18天时在胎肝中表达,相对于成年鼠表达水平较低,且未被MC、βNF或苯巴比妥(PB)经胎盘诱导。这些结果表明:(1)胎鼠肝脏晚期至少存在两种对酚类底物功能不同的UDPGT活性;(2)其中一种可被βNF和MC经胎盘诱导,但仅在C57BL/6母鼠的胎儿中;(3)诱导程度相对较小;(4)一种PB诱导的UDPGT基因在胎儿中低水平表达,且未被经胎盘诱导。